Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life
Recruiting
N/A
Interventional Study
Glioma
Glioma, Malignant
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 400 (estimated)
- Sponsor
- University of Milan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Background Lower-grade-gliomas affect young patients, thus the longest progression-free-survival (PFS) with a high level quality of life is crucial. Surgery most significantly impacts on tumor natural history, postponing recurrence, improving symptoms, decreasing the need of adjuvant therapies, with extent of resection, gross-total and supra-total (GTR and STR), strongly associating with longest P…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria (ARM 1):
* Patients signing informed consent for participation in the study
* Males and females
* Age ≥ 18 years
* Patients with lower-grade gliomas with involvement of the motor pathways who are candidates for surgery
Inclusion Criteria (ARM 2/3/4):
* Patients signing informed…
Contacts